UPDATE: Ligand Pharmaceuticals Q3 Earnings Beat Street View

By: via Benzinga
Ligand Pharmaceuticals (NASDAQ: LGND) reported upbeat earnings for the third quarter. The La Jolla, California-based company posted ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.